X T L Biopharmaceuticals reported $533K in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
Alaunos Therapeutics USD 970K 1.02M Mar/2026
Bioline Rx USD 28.52M 3.34M Sep/2025
Teva Pharmaceutical Industries USD 13.71B 236M Mar/2026
X T L Biopharmaceuticals USD 533K 807K Jun/2025